Pituitary
短名 | Pituitary |
Journal Impact | 3.48 |
国际分区 | ENDOCRINOLOGY & METABOLISM(Q2) |
期刊索引 | SCI Q2中科院 2 区 |
ISSN | 1386-341X, 1573-7403 |
h-index | 81 |
国内分区 | 医学(2区)医学内分泌学与代谢(2区) |
PITUITARY 是一本国际出版物,专门介绍垂体的基本和临床方面。它旨在发表关于基础和垂体功能以及临床垂体疾病的原创、高质量研究。该杂志认为:垂体肿瘤生物学垂体激素分泌机制垂体功能的调节垂体疾病的前瞻性临床研究关键基础和临床评论垂体是针对对垂体及其疾病的广泛领域感兴趣的基础研究人员、生理学家、临床成人和儿童内分泌学家、神经外科医生和生殖内分泌学家。编委由基础和临床内分泌学领域的国际专家组成。该期刊为审稿提供了快速的周转时间,并且该期刊的高标准是通过选择性的同行评审过程来保持的,该过程旨在仅发表最高质量的手稿。垂体将促进与垂体有关的创造性学术研究的出版,并将为基础科学家和临床医生提供一个发表高质量垂体相关工作的论坛。
期刊主页投稿网址涉及主题 | 医学生物内科学内分泌学化学生物化学病理激素遗传学外科心理学生长激素放射科腺瘤垂体腺瘤肢端肥大症儿科神经科学垂体 |
出版信息 | 出版商: Springer,出版周期: Quarterly,期刊类型: journal |
基本数据 | 创刊年份: 1998,原创研究文献占比: 81.91%,自引率:6.10%, Gold OA占比: 31.73% |
平均审稿周期 | 网友分享经验:平均6月 |
平均录用比例 | 网友分享经验:约75% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center
2024-9-13
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience
2024-9-12
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center
2024-9-9
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome
2024-9-9
Natural history of untreated microprolactinomas
2024-9-8
GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism
2024-9-6
Long COVID and pituitary dysfunctions: a bidirectional relationship?
2024-9-6
Skeletal fragility in pituitary disease: how can we predict fracture risk?
2024-9-6
Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis
2024-8-31
Is semaglutide a target therapy for acquired hypothalamic obesity?
2024-8-30
Does size really matter? A closer look at the absolute size of growth hormone-secreting pituitary adenomas
2024-8-30
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19
2024-8-28
Vitamin D in pituitary driven osteopathies
2024-8-24
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly
2024-8-19
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists
2024-8-19
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”
2024-8-14
Semaglutide treatment of hypothalamic obesity – a real-life data study
2024-8-9
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism
2024-8-9
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era
2024-8-5
Neuroendocrinology of bone
2024-8-3
Is diabetes with acromegaly for life?
2024-8-1
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis
2024-8-1
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
2024-8-1
Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study
2024-7-29
The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas
2024-7-27
Precocious puberty, pandemic and beyond
2024-7-26
Craniofacial impact of acromegaly: when muscle ma-sse-tter
2024-7-26
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence
2024-7-24
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants
2024-7-23
Copeptin after pituitary surgery: is it worth measuring?
2024-7-16
Cushing’s disease and bone
2024-7-15
Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent
2024-7-12
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders
2024-7-8
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients
2024-7-5
Impact of medical therapy for hormone-secreting Pituitary tumors on bone
2024-7-5
Pituitary surgery and COVID
2024-7-5
Decreased β-cell volume and insulin secretion but preserved glucose tolerance in a growth hormone insensitive pig model
2024-7-3
Correction: Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery
2024-6-28
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
2024-6-28
Cardiac MRI in acromegaly: looking for a big heart
2024-6-28
Pituitary apoplexy: a systematic review of non-gestational risk factors
2024-6-27
Pituitary tumor centers of excellence (PTCOE): the next border of acromegaly treatment
2024-6-25
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification
2024-6-19
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly
2024-6-19
The conundrum of differentiating Cushing’s syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis
2024-6-18
Vertebral fractures in patients with non-functioning pituitary adenomas - a new frontier?
2024-6-14
Pituitary apoplexy in cushing’s disease: a single center study and systematic literature review
2024-6-8
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study
2024-6-7
Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery
2024-6-7
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)
2024-6-4
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远